Economic evaluation of rivaroxaban in stroke prevention for patients with atrial fibrillation in Greece
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-7547
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Economic evaluation of rivaroxaban in stroke prevention for patients with atrial fibrillation in Greece ; volume:12 ; number:1 ; day:10 ; month:2 ; year:2014 ; pages:1-10 ; date:12.2014
Cost effectiveness and resource allocation ; 12, Heft 1 (10.2.2014), 1-10, 12.2014
- Creator
-
Kourlaba, Georgia
Maniadakis, Nikos
Andrikopoulos, George
Vardas, Panos
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1478-7547-12-5
- URN
-
urn:nbn:de:101:1-2019063010363226200432
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kourlaba, Georgia
- Maniadakis, Nikos
- Andrikopoulos, George
- Vardas, Panos
- SpringerLink (Online service)
Other Objects (12)
Beyond Stroke Prevention in Atrial Fibrillation: Exploring Further Unmet Needs with Rivaroxaban
Initial rivaroxaban dosing in patients with atrial fibrillation
Stroke prevention in atrial fibrillation
Understanding the Value of Real-World Evidence: Focus on Stroke Prevention in Atrial Fibrillation with Rivaroxaban
Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation
Cost-Effectiveness of Rivaroxaban Versus Warfarin for Stroke Prevention in Atrial Fibrillation in the Belgian Healthcare Setting
Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation
Rivaroxaban in Valvular Atrial Fibrillation — a Critical Appraisal of the INVICTUS Trial
Outcomes of mechanical thrombectomy in acute stroke patients with atrial fibrillation detected after stroke versus known atrial fibrillation
Rivaroxaban Underdose for Atrial Fibrillation with Stable Coronary Disease: The AFIRE Trial Findings
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)
Improving stroke prevention in patients with atrial fibrillation
Beyond Stroke Prevention in Atrial Fibrillation: Exploring Further Unmet Needs with Rivaroxaban
Initial rivaroxaban dosing in patients with atrial fibrillation
Stroke prevention in atrial fibrillation
Understanding the Value of Real-World Evidence: Focus on Stroke Prevention in Atrial Fibrillation with Rivaroxaban
Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation
Cost-Effectiveness of Rivaroxaban Versus Warfarin for Stroke Prevention in Atrial Fibrillation in the Belgian Healthcare Setting
Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation
Rivaroxaban in Valvular Atrial Fibrillation — a Critical Appraisal of the INVICTUS Trial
Outcomes of mechanical thrombectomy in acute stroke patients with atrial fibrillation detected after stroke versus known atrial fibrillation
Rivaroxaban Underdose for Atrial Fibrillation with Stable Coronary Disease: The AFIRE Trial Findings
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)
Improving stroke prevention in patients with atrial fibrillation
Beyond Stroke Prevention in Atrial Fibrillation: Exploring Further Unmet Needs with Rivaroxaban
Initial rivaroxaban dosing in patients with atrial fibrillation
Stroke prevention in atrial fibrillation
Understanding the Value of Real-World Evidence: Focus on Stroke Prevention in Atrial Fibrillation with Rivaroxaban
Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation
Cost-Effectiveness of Rivaroxaban Versus Warfarin for Stroke Prevention in Atrial Fibrillation in the Belgian Healthcare Setting
Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation
Rivaroxaban in Valvular Atrial Fibrillation — a Critical Appraisal of the INVICTUS Trial
Outcomes of mechanical thrombectomy in acute stroke patients with atrial fibrillation detected after stroke versus known atrial fibrillation
Rivaroxaban Underdose for Atrial Fibrillation with Stable Coronary Disease: The AFIRE Trial Findings
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)